The Journey to an Infection Prevention and Control Career In the complex world of health care, infection prevention and control (IPC) is crucial to keeping everyone safe. IPC helps protect healthcare professionals and reduces patients’ risk for healthcare-associated infections (HAIs), which they can get while or soon after receiving care. HAIs can lead to prolonged…
The 360X standards are designed to improve referral management, close communication gaps and enable transparency between care settings
This fact sheet provides an overview of U.S. government global health policy and engagement.
Penn researchers have received funding from Advanced Research Projects Agency for Health (ARPA-H) to focus on breast cancer, heart attacks and sepsis
A review of the 2025 Medicare Advantage plans available for individual enrollment shows that the total number of plans declined by 7% (from 3,959 to 3,699). The average Medicare beneficiary will have the option of 34 Medicare Advantage prescription drug (MA-PD) plans in 2025, just 2 fewer than the 36 options available in 2024. Since…
PurpleLab® stands out from others in this sector by providing its data analytics services to several different groups of users across healthcare and pharma companies. The post The Future of Hospitals and Pharma Companies Will Depend on Strength of Healthcare Analytics Insights appeared first on MedCity News.
Payers and providers alike are struggling with data interoperability. It’s clear that a more unified approach to data management is essential for payers to effectively navigate the complexities of value-based care. The post Finding the Cure for Data Interoperability in Value-Based Care appeared first on MedCity News.
Healthcare is a data-driven industry, but it’s held together by incompatible, siloed data systems. Providers and payers need the ability to exchange data and update directories in real time; otherwise, they cannot ensure patients will access the high-quality care they deserve. The post Inaccurate Provider Data Hinders Value-based Care, But it Doesn’t Have To appeared…
This brief analyzes the latest CDC data on adolescent overdose deaths, finding that from 2022 to 2023, there was a small reduction in overdose fatalities among adolescents (from 721 to 708 deaths). Additionally, the synthetic opioid, fentanyl, has largely driven the increase in adolescent drug fatalities since the pandemic began, accounting for 76% of these…
In the U.S., Hispanic/Latino people have been disproportionately affected by HIV since the epidemic’s beginning, and that disparity has deepened over time. Hispanic/Latino people represent a larger share of HIV diagnoses and people estimated to be living with HIV relative to their population size. This fact sheet provides an overview of the impact of HIV…